Evidence map›Paper›PMID 40195318›Full record

ArticleNature communications2025

Enabling new insights from old scans by repurposing clinical MRI archives for multiple sclerosis research.

Philipp Goebl, Jed Wingrove, Omar Abdelmannan, Barbara Brito Vega, Jonathan Stutters, Silvia Da Graca Ramos, Owain Kenway, Thomas Rossor, Evangeline Wassmer, Douglas L Arnold and 14 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Mechanistic Insights into the Role of Artificial Intelligence and Machine Learning in the Diagnosis and Management of Multiple Sclerosis.Pathophysiology : the official journal of the International Society for Pathophysiology · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Philipp GoeblQueen Square Multiple Sclerosis Centre, Department of Neuroinflammation, Faculty of Brain Sciences, University College London, London, UK. p.goebl@ucl.ac.uk.ORCID http://orcid.org/0000-0002-4970-2340
Jed WingroveQueen Square Multiple Sclerosis Centre, Department of Neuroinflammation, Faculty of Brain Sciences, University College London, London, UK.
Omar AbdelmannanQueen Square Multiple Sclerosis Centre, Department of Neuroinflammation, Faculty of Brain Sciences, University College London, London, UK.
Barbara Brito VegaQueen Square Multiple Sclerosis Centre, Department of Neuroinflammation, Faculty of Brain Sciences, University College London, London, UK.ORCID http://orcid.org/0000-0002-0476-7220
Jonathan StuttersQueen Square Multiple Sclerosis Centre, Department of Neuroinflammation, Faculty of Brain Sciences, University College London, London, UK.
Silvia Da Graca RamosCentre for Advanced Research Computing (ARC), University College London, London, UK.
Owain KenwayCentre for Advanced Research Computing (ARC), University College London, London, UK.
Thomas RossorDepartment of Paediatric Neurology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
Evangeline WassmerBirmingham Children's Hospital, Birmingham, United Kingdom.ORCID http://orcid.org/0000-0002-2446-1106
Douglas L ArnoldMcConnell Brain Imaging Centre, Montreal Neurological Institute-Hospital, Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada.ORCID http://orcid.org/0000-0003-4266-0106
D Louis CollinsMcConnell Brain Imaging Centre, Montreal Neurological Institute-Hospital, Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada.ORCID http://orcid.org/0000-0002-8432-7021
Cheryl HemingwayDepartment of Paediatric Neurology, Great Ormond Street Hospital, London, UK; Institute of Neurology, UCL, London, UK.
Sridar NarayananMcConnell Brain Imaging Centre, Montreal Neurological Institute-Hospital, Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada.ORCID http://orcid.org/0000-0002-6283-150X
Jeremy ChatawayQueen Square Multiple Sclerosis Centre, Department of Neuroinflammation, Faculty of Brain Sciences, University College London, London, UK.
Declan ChardQueen Square Multiple Sclerosis Centre, Department of Neuroinflammation, Faculty of Brain Sciences, University College London, London, UK.ORCID http://orcid.org/0000-0003-3076-2682
Juan Eugenio IglesiasUCL Hawkes Institute, University College London, London, UK.
Frederik BarkhofQueen Square Multiple Sclerosis Centre, Department of Neuroinflammation, Faculty of Brain Sciences, University College London, London, UK.ORCID http://orcid.org/0000-0003-3543-3706
Geoff J M ParkerUCL Hawkes Institute, University College London, London, UK.
Neil P OxtobyUCL Hawkes Institute, University College London, London, UK.ORCID http://orcid.org/0000-0003-0203-3909
Yael HacohenQueen Square Multiple Sclerosis Centre, Department of Neuroinflammation, Faculty of Brain Sciences, University College London, London, UK.
Alan ThompsonQueen Square Multiple Sclerosis Centre, Department of Neuroinflammation, Faculty of Brain Sciences, University College London, London, UK.ORCID http://orcid.org/0000-0002-4333-8496
Daniel C AlexanderUCL Hawkes Institute, University College London, London, UK.ORCID http://orcid.org/0000-0003-2439-350X
Olga CiccarelliQueen Square Multiple Sclerosis Centre, Department of Neuroinflammation, Faculty of Brain Sciences, University College London, London, UK.ORCID http://orcid.org/0000-0001-7485-1367
Arman EshaghiQueen Square Multiple Sclerosis Centre, Department of Neuroinflammation, Faculty of Brain Sciences, University College London, London, UK.ORCID http://orcid.org/0000-0002-6652-3512

Funding

Functionally guided adult whole brain cell atlas in human and NHPUM1MH130981 · NIMH · ALLEN INSTITUTE · PI Ed Lein, Hongkui Zeng · 2022 to 2026
$91.9M
Acquisition-independent machine learning for morphometric analysis of underrepresented aging populations with clinical and low-field brain MRIRF1AG080371 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI Juan Eugenio Iglesias Gonzalez · 2023 to 2026
$4.0M
Portable, Low Field Brain Magnetic Resonance Imaging (MRI) for Acute StrokeR01EB031114 · NIBIB · YALE UNIVERSITY · PI William Taylor Kimberly, Matthew Scot Rosen · 2022 to 2026
$3.5M
Diagnosing the undiagnosable: studies of Alzheimer disease mimics and confounders via "neuropathometry" of dissection photos with 3D scanningR01AG070988 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI IGLESIAS GONZALEZ, JUAN EUGENIO · 2021 to 2025
$2.7M
Open-source software for multi-scale mapping of the human brainRF1MH123195 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI FISCHL, BRUCE, IGLESIAS GONZALEZ, JUAN EUGENIO · 2020 to 2020
$2.0M
Measuring Brain Health Using Low-Field Portable MRIR21NS138995 · NINDS · YALE UNIVERSITY · PI DE HAVENON, ADAM H. · 2024 to 2024
$477k
DH | National Institute for Health Research (NIHR) NIHR302495NIA NIH HHS R01 AG070988NIA NIH HHS RF1 AG080371NIBIB NIH HHS R01 EB031114NIMH NIH HHS RF1 MH123195NIMH NIH HHS UM1 MH130981NINDS NIH HHS R21 NS138995
6 · The paper itself

Abstract

Magnetic resonance imaging (MRI) biomarkers are vital for multiple sclerosis (MS) clinical research and trials but quantifying them requires multi-contrast protocols and limits the use of abundant single-contrast hospital archives. We developed MindGlide, a deep learning model to extract brain region and white matter lesion volumes from any single MRI contrast. We trained MindGlide on 4247 brain MRI scans from 2934 MS patients across 592 scanners, and externally validated it using 14,952 scans from 1,001 patients in two clinical trials (primary-progressive MS and secondary-progressive MS trials) and a routine-care MS dataset. The model outperformed two state-of-the-art models when tested against expert-labelled lesion volumes. In clinical trials, MindGlide detected treatment effects on T2-lesion accrual and cortical and deep grey matter volume loss. In routine-care data, T2-lesion volume increased with moderate-efficacy treatment but remained stable with high-efficacy treatment. MindGlide uniquely enables quantitative analysis of archival single-contrast MRIs, unlocking insights from untapped hospital datasets.

Indexed as

BrainMagnetic Resonance ImagingMultiple SclerosisAdultDeep LearningFemaleGray MatterHumansMaleMiddle AgedWhite Matter

Identifiers

PMID40195318
PMCPMC11976987

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.